My WordPress Blog
The U.S. FDA provides multiple 510(k) pathways to streamline medical device clearance, including the Special 510(k) and Abbreviated 510(k) routes. Selecting the correct pathway is essential for efficient review, regulatory compliance, and avoiding unnecessary delays or additional testing. At XPRO AMERICA, we specialize in guiding manufacturers through these specialized pathways, [...]
Premarket Approval (PMA) is the FDA’s regulatory pathway for high-risk Class III medical devices, which require extensive scientific evidence demonstrating safety and effectiveness before marketing in the United States. Unlike 510(k) or De Novo submissions, PMA applications often involve clinical study data and rigorous review processes. At XPRO AMERICA, we [...]
An Investigational Device Exemption (IDE) allows medical device manufacturers to conduct clinical trials in the United States using investigational devices that have not yet received FDA clearance or approval. IDE submissions enable the collection of safety and effectiveness data essential for regulatory pathways such as 510(k), De Novo, or PMA. [...]
The De Novo classification pathway is designed for novel, low- to moderate-risk medical devices that do not have a predicate device for 510(k) submission. This pathway allows manufacturers to obtain FDA marketing authorization by demonstrating safety and effectiveness while establishing a new device classification. At XPRO AMERICA, we provide expert [...]